Literature DB >> 8619005

Effects of Antidepressants and antipsychotics on the 5HT2 receptor-mediated signal transducing system in human platelets.

N Ohsuka1, H Mashiko, M Kaneko, H Kumashiro.   

Abstract

The IC50 values of the antidepressants amoxapine, mianserin, desipramine, clomipramine and imipramine, and the antipsychotics spiroperidol, chlorpromazine, levomepromazine and haloperidol for 3H-ketanserin binding, 5HT-induced intracellular Ca2+ increase, 5HT-induced shape change and 3H-paroxetine binding in human platelets were measured and the correlations of each parameter were examined. Results were as follows. Both the antidepressants and the antipsychotics had inhibitory effects on 3H-ketanserin binding, 5HT-induced intracellular Ca2+ increase and 5HT-induced shape change and there were significant positive correlations between the IC50 values of these three parameters. On the other hand, there were no significant correlations between the IC50 values in 3H-paroxetine binding and those in the other three parameters. These results suggest that 3H-ketanserin binding, 5HT-induced intracellular Ca2+ increase and 5HT-induced shape change are useful and reliable tools for the assessment of the effects of the antidepressants and the antipsychotics on the 5HT2 receptor-mediated signal transducing system in human platelets.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8619005     DOI: 10.1007/bf02246490

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets.

Authors:  H Affolter; P Erne; E Bürgisser; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

3.  The involvement of 5-HT2-receptor sites in the activation of cat platelets.

Authors:  F De Clerck; B Xhonneux; J Leysen; P A Janssen
Journal:  Thromb Res       Date:  1984-02-01       Impact factor: 3.944

4.  Characterization of serotonin binding sites on human platelets.

Authors:  P A McBride; J J Mann; B McEwen; A Biegon
Journal:  Life Sci       Date:  1983-11-14       Impact factor: 5.037

5.  Imipramine binding site. Temperature dependence of the binding of 3H-labeled imipramine and 3H-labeled paroxetine to human platelet membrane.

Authors:  P Plenge; E T Mellerup
Journal:  Biochim Biophys Acta       Date:  1984-02-29

6.  Shape change of blood platelets--a model for cerebral 5-hydroxytryptamine receptors?

Authors:  M Graf; A Pletscher
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

7.  The 5-hydroxytryptamine receptor of blood platelets.

Authors:  A Pletscher; H Affolter
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

8.  Blood platelets as models for neurons: uses and limitations.

Authors:  A Pletscher; A Laubscher
Journal:  J Neural Transm Suppl       Date:  1980

9.  Assessment of binding indices and physiological responsiveness of the 5-HT2 receptor on human platelets.

Authors:  P A McBride; J J Mann; M J Polley; A J Wiley; J A Sweeney
Journal:  Life Sci       Date:  1987-05-04       Impact factor: 5.037

10.  Platelet 3H-paroxetine binding in depressed patients.

Authors:  H D'haenen; M De Waele; J E Leysen
Journal:  Psychiatry Res       Date:  1988-10       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.